
The Coming Preclinical Licensing Bottleneck
Will AI create more assets than pharma can absorb? AI is often discussed as
We have a range of services specifically tailored to the needs of business development and licensing pros:
We cover and comment on interesting news and trends in our industry

Will AI create more assets than pharma can absorb? AI is often discussed as

What is a “reach through? Let me paint the picture. Company A licenses technology

After ~six months of integrating AI into our workflows at Lacerta Bio (plus building
Collectively, we have decades of experience in consulting and business development. Let us bring this experience to help you solve your challenging in-licensing and out-licensing problems.